Family · Pharmaceutical analytical standards
Zoledronic Acid
A bisphosphonate carrying an imidazole ring, patented in 1986 and approved in the United States in 2001: it strengthens bone by restraining osteoclasts and is used for osteoporosis, Paget's disease, bone metastases and hypercalcaemia of cancer. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards and other impurities.
Did you know?It is among the most potent bisphosphonates: in relative potency tables, where the older etidronate scores 1, zoledronic acid reaches 10,000.
No product matches your search.
EDQM standards 3
The official European Pharmacopoeia standards for this family.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
